SCHEMBL1844868

SCHEMBL1844868

Cc1nc2ccc(Cl)cc2c2[nH]cnc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
RXFP1 Q9HBX9 1/20 0.41
FABP3 P05413 1/20 0.41
FABP4 P15090 1/20 0.41
HSP90AB1 P08238 2/20 0.40
MPO P05164 1/20 0.40
ALDH1A1 P00352 4/20 0.40
PIM3 Q86V86 3/20 0.40
PIM1 P11309 2/20 0.40
CDC7 O00311 1/20 0.40
DYRK3 O43781 1/20 0.40
IGF1R P08069 1/20 0.40
CLK2 P49760 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
CSNK2A1 P68400 1/20 0.40
DYRK1A Q13627 1/20 0.40
PKN2 Q16513 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
PIM2 Q9P1W9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL405945 0.84 PARP1 (0.49) PARP1RXFP1ALDH1A1PIM3PIM1
Water SCHEMBL9602170 0.81 CASP3 (0.47) PARP1HSP90AB1MPOMEN1MAPT
SCHEMBL5528653 0.78 GPR3 (0.48) PARP1ALDH1A1HSD17B10
SCHEMBL405015 0.75 HRH4 (0.54) ALDH1A1KDM4EUSP2
SCHEMBL30182296 0.74 PDPK1 (0.32)
SCHEMBL405419 0.74 KDM4E (0.49) KDM4EKMT2A
SCHEMBL25021728 0.71 PARP1 (0.60) PARP1RXFP1ALDH1A1PIM3PIM1
SCHEMBL2122835 0.68 MPO (0.51) RXFP1FABP3FABP4HSP90AB1MPO
SCHEMBL405016 0.68 ALDH1A1 (0.50) HSP90AB1MPOALDH1A1PIM3PIM1
SCHEMBL12501269 0.68 MPO (0.58) FABP3FABP4HSP90AB1MPOALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2324029-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE Kalypsys, Inc. (US) 2011-05-25 EP disclosed
WO-2010030785-A2 HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE KALYPSYS INC. (US) 2010-03-18 WO disclosed